AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Kakatiya University

Status: Completed

Conditions: Gender Discrimination; Complication; Cardiac Event

Treatments: Behavioral: Difference in gender, response to disease, diagnostic test values

Study type: Observational

Funder types: Other

Identifiers

NCT05710796

IECHS/CCP/DOPP/09/04

Details and patient eligibility

About

Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

Full description

The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients.

Objectives of the study:

1. To study causes and risk factors of cardiac disorders associated with COVID-19
2. To identify different types of cardiac symptoms patients, present with
3. To study the impact of co-morbidities on COVID-19 recovered patients
4. To study treatment patterns and duration of therapy

Plan to study:

• To select the patient based on inclusion and exclusion criteria
• To collect the patient information from case sheets and by patient interaction
• To identify different types of cardiac disorders related to COVID-19 or its treatment regimen
• To study the management of COVID-19 complication and related cardiovascular disorders

Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months

Subject Eligibility:

1. Inclusion Criteria

   • Patients who are willing to participate
   • Patients having previous COVID-19 treatment record
   • Prescriptions reported during the study period
   • The prescription which is legible and complete

2. Exclusion Criteria

   • Patients who are not willing to participate
   • The patient having no history of COVID-19 and available data

Source of the data:

1. Review of patient case sheet, prescription and lab reports
2. Personal interaction with patients and caregivers

Sample size: 500 Patients

Enrollment: 500 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are willing to participate
• Patients having previous COVID-19 treatment record
• Prescriptions reported during the study period
• The prescription which is legible and complete

Exclusion criteria

• Patients who are not willing to participate
• The patient having no history of COVID-19 and available data

Trial design

500 participants in 3 patient groups

All population

Description:

The total population reported to Cardiology department during enrollment period

Treatment:

Behavioral: Difference in gender, response to disease, diagnostic test values

COVID recovered

Description:

Patient having history of COVID 19 disease

Treatment:

Behavioral: Difference in gender, response to disease, diagnostic test values

No history of COVID

Description:

Population those who never exposed to COVID 19 disease and never suffers

Treatment:

Behavioral: Difference in gender, response to disease, diagnostic test values